Joslin Diabetes Ctr Awarded $5M

Boston – Joslin Diabetes Center has received a $5 million grant from the Massachusetts Life Sciences Center. The grant is among the highest amounts ever received to support diabetes research in Massachusetts.
Joslin will match the Center’s grant with funds raised from Joslin donors. A total of $10.8 million will be used to build a comprehensive Translational Center for the Cure of Diabetes at Joslin’s location in the heart of Boston’s Longwood Medical Area.
“We are very grateful to the Massachusetts Life Sciences Center for funding this project,” said Sharon Harpel, Vice President of Research Administration at Joslin. “We are also grateful to our donors for providing the required matching funds.”
“The Translational Center for the Cure of Diabetes will enable us to accelerate our clinical and research endeavors,” according to Dr. George King, Joslin’s Chief Scientific Officer. “It will ensure we have the most up to date infrastructure, through the creation of new labs and new platforms, that will lead to the development of translational studies for curing Type 1 and Type 2 diabetes, and their complications, as well as advancing our work in diabetes prevention and obesity.“